Navigation Links
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
Date:4/27/2008

a generous gift from the F.M. Kirby Foundation, which has provided continuous support for the ongoing research for the past 14 years. The F.M. Kirby Center was the first molecular biology center devoted to developing gene therapy for hereditary causes of vision loss. The Center serves as home to the laboratories of seven investigators who conduct research on the cellular and molecular biology of eye disease and visual function. Current studies in the F.M. Kirby Center include evaluations of the molecular genetics and pathogenetic mechanisms involved in optic nerve disease and inherited retinal and macular degenerations, cell biology studies of photoreceptor sensory cilia, delineation of mechanisms underlying the light responses of rods and cones, gene discovery of complex and monogenic disorders, development of methods with which to non-invasively monitor retinal and visual function in animal models and humans, and design of novel methods with which to image retinal cells. (http://www.uphs.upenn.edu/news)

The Department of Ophthalmology (Scheie Eye Institute) at Penn is a world leader in patient care and eye and vision research. In 2006, the most recent year for which published data are available, Scheie Eye Institute was the #1 recipient of eye research funds from the National Eye Institute, National Institutes of Health among all departments of ophthalmology in the United States. Currently the National Eye Institute is funding a 46-site randomized clinical trial to evaluate treatment strategies for age-related macular degeneration coordinated by faculty at Scheie Eye Institute at Penn.

About The Telethon Institute of Genetics and Medicine (TIGEM): TIGEM is a local and international reference for research on human genetic diseases. It was created in 1994 by the Telethon Foundation, one of Italy's major non-profit organizations, to promote the advancement of research aimed at the diagnosis
'/>"/>

SOURCE The Children's Hospital of Philadelphia; University ofPennsylvania
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Gene Therapy Provides Vision to People who Were Nearly Blind
2. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
3. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
4. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
5. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
6. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
7. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
8. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
9. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
10. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
11. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
(Date:5/5/2015)... LAVAL, QC , May 5, 2015 /CNW Telbec/ ... in Laval and known under ... announces today the closing of the transaction previously announced ... of the issued and outstanding  shares of Orthoconcept (2008) ... by issuing 500 000 common shares (TSXV: ERG) to ...
(Date:5/5/2015)... Valley Medical Center, named a Top 100 Hospitals® in the ... to deploy the wireless Leaf Patient Monitoring System in its ... labor and risk of caesarian births. Studies show ... is reduced in mothers who are upright and mobile during ... epidurals and tend to lie in their labor room beds. ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
... 11, 2011 Tonight,s "Dan Rather Reports" examines ... of antibiotics. Every year, more than 90,000 Americans ... antibiotic-resistant infections, caused directly by the overuse of ... $35 billion a year.  In tonight,s program, Dan ...
... 2011 WebMD Health Corp. (Nasdaq: WBMD ) ... million aggregate principal amount of 2.50% Convertible Notes due 2018 ... the exercise in full of the initial purchaser,s over-allotment option). ... to Rule 144A under the Securities Act of 1933.   ...
Cached Medicine Technology:Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 2Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 3Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 4WebMD Closes Offering of 2.50% Convertible Notes Due 2018 2
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 With ProPoint: ... all within Final Cut Pro X . With ... within 3D space to further more customize each preset all ... users are given up to 90 fully customizable effect presets ... boxes, circles, curved arrows, straight arrows, underlines, and more. ...
(Date:5/5/2015)... Cosmetic Dentist, Arthur Glosman released a luxury line of advanced ... offices of Arthur Glosman DDS, 450 N Roxbury Drive Suite ... store . “I wanted to be one of the first ... with a luxurious collection of products designed to make you ... Glosman’s Advanced Dental Health + Beauty™ products use a potent ...
(Date:5/5/2015)... New Jersey (PRWEB) May 05, 2015 ... has maintained its strong and secure credit rating of ... of Horizon BCBSNJ’s financials last week, the Wall Street ... adequacy” and “leading market position” in determining the rating ... of mind is one of our top priorities, so ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
Breaking Medicine News(10 mins):Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3
... sensitive tooth at some point of their life. A visit to ... or 'you brush in a hard way, so your teeth are ... out with a solution that could make sensitive teeth a bad ... out the dentinal tubules which transmit painful signals to the pulp, ...
... to fund a study which helps to understand the ... to breast cancer patients to ease the pain they ... study is to be carried out by Researchers from ... the three complementary therapy methods reflexology, guided imagery and ...
... one of the most common breathing problems encountered by ... has been a considerable increase in the incidence of ... been estimated that nearly 196,000 children are hospitalized in ... considerable amount is being spent on the health issue ...
... loss of motor function in a part due to ... Lateral Sclerosis// is a form of motor neuron disease ... incapable of even the slightest movements such as blinking. ... ,The new headband that has been developed by Japanese ...
... year India’s Health care has been in constant limelight ... the healthcare system in India came to focus after ... the City leaving thousands homeless, many orphaned and a ... worked quickly and effectively with the people providing immediate ...
... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
Cached Medicine News:Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... placement to stent the ureter ... continent urinary diversions. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... remain indwelling more than six ...
... The Bard® C-Max™ Cutting Loop is ... smooth tissue cut. The cutting loops are ... standard. The tungsten wire-cutting loop is hand ... process. These electrodes are made to exacting ...
Medicine Products: